Molecular subtype conversion in CTCs as indicator of treatment adequacy associated with metastasis-free survival in breast cancer

Molecular subtype of breast cancer has a great clinical significance and used as one of the major criteria for therapeutic strategy. Recently, for anticancer therapy, the trend for oncologists is the predominant determination of biomarkers in the existing foci of the disease. In the case of adjuvant...

Descripción completa

Detalles Bibliográficos
Autores principales: Grigoryeva, E. S., A.Tashireva, L., Alifanov, V. V., Savelieva, O. E., Vtorushin, S. V., Zavyalova, M. V., Bragina, O. D., Garbukov, E. Y., Cherdyntseva, N. V., Choinzonov, E. L., Perelmuter, V. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9723174/
https://www.ncbi.nlm.nih.gov/pubmed/36470982
http://dx.doi.org/10.1038/s41598-022-25609-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9723174/
https://www.ncbi.nlm.nih.gov/pubmed/36470982
http://dx.doi.org/10.1038/s41598-022-25609-0

Ejemplares similares